Skincare ad claims in India: the rules, and how to sell inside them

The four rulebooks that govern skincare ads

There's no single "skincare advertising law" in India; there's a stack. The Drugs & Cosmetics Act, 1940 (with the Cosmetics Rules, 2020) defines what a cosmetic is and, crucially, what claims push a product into drug territory. The Drugs & Magic Remedies (Objectionable Advertisements) Act, 1954 bans advertising cures for a schedule of conditions outright. ASCI's code – self-regulatory but taken seriously by platforms and the press – requires claims to be substantiated and covers influencer disclosure. The CCPA's 2022 guidelines on misleading advertisements gave the consumer-protection regulator teeth, including penalties and liability that can extend to endorsers.

On top of all four sit Meta's and Google's ad policies, which reject plenty of ads that would pass every Indian rulebook. You have to clear both layers; this post is a working map, not legal advice – for launch decisions on regulated claims, get counsel.

Why care beyond fines? Because enforcement is no longer theoretical. ASCI processes thousands of complaints a year with personal care persistently among the most-complained-about categories, the CCPA has shown it will act on endorsements, and platform enforcement is automated, instant, and indifferent to your appeal queue.

The line between a cosmetic and a drug claim

This is the boundary most skincare trouble starts at. A cosmetic cleanses, beautifies or improves appearance. The moment your copy claims to treat, cure or prevent a condition – acne as a disease, eczema, fungal infection, pigmentation disorders – you're describing a drug, and a cosmetic licence doesn't cover drug claims. The product hasn't changed; your sentence reclassified it.

In practice the same ingredient story can be told on either side of the line. "Treats acne" is a drug claim. "Helps reduce the appearance of blemishes, with 2% salicylic acid" is a cosmetic claim about appearance with a substantiating ingredient. The second version is legal, platform-safe and – in our experience running skincare accounts – converts perfectly well, because buyers respond to specificity more than to medical promises.

The same logic covers anti-ageing, dandruff, hair-fall and sun protection: the closer your sentence gets to a medical outcome, the closer you are to needing a licence you don't hold. When in doubt, claim the visible change, name the ingredient and concentration, and let reviews say the rest.

Claims that get skincare brands in trouble

The recurring offenders, across regulator actions, ASCI complaint reports and platform rejections:

• Cure/treat language: "cures acne", "treats eczema", "heals scars" – drug claims on cosmetic products.
• Permanence promises: "permanent fairness", "removes wrinkles forever" – unsubstantiable on their face.
• Fairness and tone claims: ASCI's code specifically restricts ads that link skin tone to success or attractiveness; whitening promises draw complaints and platform rejections both.
• Fake clinical dressing: "dermatologist recommended" with no dermatologist, "clinically proven" with no study, invented percentages ("reduces dark spots by 90%").
• Before/after imagery: even when genuine, it trips Meta's personal-appearance policies and invites substantiation demands you may not be able to meet.
• Undisclosed influencer promotion: ASCI's influencer guidelines require clear labels; the CCPA framework adds legal exposure for endorsers.

Each of these has sunk real campaigns. If a claim in your current ads matches this list, fix it before scaling spend – enforcement, human or algorithmic, finds scaled ads first.

How to write claims that survive scrutiny

The compliant playbook is more specific, not more boring. Anchor claims to appearance ("reduces the appearance of", "visibly brightens"), to ingredients at stated concentrations ("with 10% niacinamide"), and to sensory truth ("non-greasy", "fragrance-free") – all substantiable without a drug licence. Where you have real evidence, use it precisely: "clinically tested" means the test happened; "clinically proven to X" means you hold a study demonstrating X, and you should keep it in a substantiation file per claim before the ad runs, because ASCI and the CCPA both put the burden on you.

And design the whole surface consistently: platform reviewers and regulators read your landing page and reviews, not just the ad. A compliant ad pointing at a "cures pigmentation" PDP inherits the problem. This is the same discipline your label copy already lives under – the mindset carries over directly from FSSAI-era label design: visible claims and legal claims must be the same claims.

The platform layer: why Meta rejects legal ads anyway

Meta's policies ban implying knowledge of personal attributes ("struggling with dark circles?"), negative self-perception plays, and unrealistic outcomes – standards stricter than Indian law in places. So a legally clean ad can still be rejected, and repeated rejections degrade the whole ad account's standing. The escalation pattern and the way out are the same ones we documented for ayurvedic brands on Meta: fix the claims surface upstream, don't cycle through fresh ad accounts.

The practical adjustment is framing: aspiration over affliction. Ads built around the result the buyer wants ("glass-skin glow") clear review far more reliably than ads built around the problem they have ("tired of acne?") – and the category's best performers in 2026 are almost all written that way.

A pre-launch claims checklist

Before any skincare campaign goes live, run every asset through this:

• Does any line claim to treat, cure or prevent a condition? Rewrite to appearance-based language.
• Is every factual claim – percentages, "clinically tested", "dermatologist approved" – backed by a document in your substantiation file?
• Do the ad, landing page, PDP and packaging make the same claims? Mismatches are where accounts die.
• Any fairness/tone messaging, before/after imagery, or personal-attribute hooks? Remove or reframe.
• Are influencer posts clearly disclosed per ASCI's guidelines?

Then go one step further and build a pre-cleared claims bank: fifteen or twenty approved sentences, each mapped to its substantiation, that every new ad and landing page assembles from. It turns compliance from a per-campaign argument into a solved problem – and it's the single habit that separates calm ad accounts from firefighting ones.

Ten minutes per asset, and it saves the weeks a restricted account costs. The wider growth playbook for the category – creative, funnels, retention – is in our guide to marketing skincare and personal care D2C brands.